Nuvectis Pharma, Inc.

Direct answer

Nuvectis Pharma, Inc. is publicly traded on NASDAQ under the ticker NVCT.

Nuvectis Pharma, Inc. operates as a biopharmaceutical firm specializing in the development of targeted therapies to address critical, unmet needs within the field of oncology. The company's innovative pipeline features NXP800, a novel compound engineered to inhibit the heat shock factor 1 pathway for treating various forms of cancer. Another promising asset is NXP900, a small molecule drug candidate crafted to...

Can you invest in Nuvectis Pharma, Inc.?

Yes. Nuvectis Pharma, Inc. is publicly traded on NASDAQ under the ticker NVCT.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Nuvectis Pharma, Inc.

Detailed equity research is provided by MarketSnap.